Darovasertib
| CAS No. | 1874276-76-2 |
|---|---|
| MDL No. | MFCD31544328 |
| MF | C22H23F3N8O |
| MW | 472.50 |
| InChI Key | XXJXHXJWQSCNPX-UHFFFAOYSA-N |
Pricing & Availability
| Pack Size | Purity | Price | Availability | Action |
|---|---|---|---|---|
| - | - | On Request | On Request | |
| Custom synthesis and bulk supply options are available upon request. | ||||
Product Information
Darovasertib is an orally available PKC inhibitor with immunosuppressive and antineoplastic properties. It inhibits PKC, preventing activation of PKC-mediated signaling pathways, which may induce cell cycle arrest and apoptosis in susceptible tumor cells.
| CAS No. | 1874276-76-2 |
|---|---|
| Product Name | Darovasertib |
Associated Conditions
Uveal Melanoma·melanoma
* The information provided here is compiled from public sources and is for reference only.